Not Signed In - Once-a-year Novartis drug slashes fracture risk in post-menopausal women
Sun, 17 Sep 2006 07:52 AM EST
... There's some good news for post menopausal women. Swiss pharma giant Novartis' Aclasta, an annual dosage drug, can cut the risk of spine fractures due to post menopausal osteoporosis (PMO) by a whopping 70 per cent and of hip fractures by as much as 40 per cent. ...
Related Topics
- Fractures
- Stress
- Risk Factors
- Women who get chickenpox during pregnancy are at risk for congenital infection of the fetus.
- Women who have treatment to save the uterus have a high risk of the cancer coming back (recurrence).
- Post Traumatic Stress Disorder
- Security Risk Assessment
- Cardiac Risk
- Drug Safety
- Prescription Drugs
- High Risk Pregnancy
- Cholecystectomy
- Post-Polio Syndrome
- Women's Health
- Drug Side Effects
- Youth Risk Behaviors
- Tubal Ligation
- Polio and Post-Polio Syndrome
- Drug Abuse
- Drug Information
email this page
print this page
bookmark this page
feedback on this page
